Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP964342.RAhfHNd6YNHqfX2zeqS5nVFHmBJ5F1seNRyhtwIwrimt4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP964342.RAhfHNd6YNHqfX2zeqS5nVFHmBJ5F1seNRyhtwIwrimt4130_assertion type Assertion NP964342.RAhfHNd6YNHqfX2zeqS5nVFHmBJ5F1seNRyhtwIwrimt4130_head.
- NP964342.RAhfHNd6YNHqfX2zeqS5nVFHmBJ5F1seNRyhtwIwrimt4130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964342.RAhfHNd6YNHqfX2zeqS5nVFHmBJ5F1seNRyhtwIwrimt4130_provenance.
- NP964342.RAhfHNd6YNHqfX2zeqS5nVFHmBJ5F1seNRyhtwIwrimt4130_assertion evidence source_evidence_literature NP964342.RAhfHNd6YNHqfX2zeqS5nVFHmBJ5F1seNRyhtwIwrimt4130_provenance.
- NP964342.RAhfHNd6YNHqfX2zeqS5nVFHmBJ5F1seNRyhtwIwrimt4130_assertion SIO_000772 23762225 NP964342.RAhfHNd6YNHqfX2zeqS5nVFHmBJ5F1seNRyhtwIwrimt4130_provenance.
- NP964342.RAhfHNd6YNHqfX2zeqS5nVFHmBJ5F1seNRyhtwIwrimt4130_assertion wasDerivedFrom befree-20150227 NP964342.RAhfHNd6YNHqfX2zeqS5nVFHmBJ5F1seNRyhtwIwrimt4130_provenance.
- NP964342.RAhfHNd6YNHqfX2zeqS5nVFHmBJ5F1seNRyhtwIwrimt4130_assertion wasGeneratedBy ECO_0000203 NP964342.RAhfHNd6YNHqfX2zeqS5nVFHmBJ5F1seNRyhtwIwrimt4130_provenance.